Champions Oncology, Inc. (FRA:2I3)

Germany · Delayed Price · Currency is EUR

4.840

-0.140 (-2.81%)

Last updated: Feb 23, 2026, 9:55 AM CET

Revenue by Segment

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016
Translational Oncology Solutions (TOS)	56.94M	50.16M	53.87M	49.11M	41.04M
Translational Oncology Solutions (TOS) Growth	13.54%	-6.90%	9.69%	19.66%	27.76%
Total	56.94M	50.16M	53.87M	49.11M	41.04M
Total Growth	13.54%	-6.90%	9.69%	19.66%	27.76%

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016
United States	56.94M	50.16M	53.87M	49.11M	41.04M
United States Growth	13.54%	-6.90%	9.69%	19.66%	27.76%
Total	56.94M	50.16M	53.87M	49.11M	41.04M
Total Growth	13.54%	-6.90%	9.69%	19.66%	27.76%

Source: S&P Global Market Intelligence.